High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility study.

по Jonkhoff, A. R., Plaizier, M. A., Ossenkoppele, G. J., Teule, G. J., Huijgens, P. C.
Опубликовано 1995

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

по Berge, R., Oudejans, J., Ossenkoppele, G., Pulford, K., Willemze, R., Falini, B., Chott, A., Meijer, C.
Опубликовано 2000

Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.

по Noorduyn, L A, de Bruin, P C, van Heerde, P, van de Sandt, M M, Ossenkoppele, G J, Meijer, C J
Опубликовано 1994

Gallium-67 radiotoxicity in human U937 lymphoma cells.

по Jonkhoff, A. R., Huijgens, P. C., Versteegh, R. T., van Dieren, E. B., Ossenkoppele, G. J., Martens, H. J., Teule, G. J.
Опубликовано 1993

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

по van der Poel, M. W. M., Mulder, W. J., Ossenkoppele, G. J., Maartense, E., Hoogendoorn, M., Wijermans, P., Schouten, H. C.
Опубликовано в: Ann Hematol (2015)

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

по Huijgens, P C, Simoons-Smit, A M, van Loenen, A C, Prooy, E, van Tinteren, H, Ossenkoppele, G J, Jonkhoff, A R
Опубликовано 1999

Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

по Kiburg, B., van de Loosdrecht, A. A., Schweitzer, K. M., Ossenkoppele, G. J., Müller, L. J., Heimans, J. J., Huijgens, P. C.
Опубликовано 1994

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

по Laukkanen, S, Grönroos, T, Pölönen, P, Kuusanmäki, H, Mehtonen, J, Cloos, J, Ossenkoppele, G, Gjertsen, B, Øystein, B, Heckman, C, Heinäniemi, M, Kontro, M, Lohi, O
Опубликовано в: Blood Cancer J (2017)

Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.

по Oudejans, J. J., Kummer, J. A., Jiwa, M., van der Valk, P., Ossenkoppele, G. J., Kluin, P. M., Kluin-Nelemans, J. C., Meijer, C. J.
Опубликовано 1996

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors

по Thijsen, S F T, Schuurhuis, G J, Oostveen, J W van, Theijsmeijer, A P, van der Hem, K G, Odding, J H, Dräger, A M, Ossenkoppele, G J
Опубликовано 1999

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the...

по Russell, Nigel, Douglas, Kenny, Ho, Anthony D., Mohty, Mohamad, Carlson, Kristina, Ossenkoppele, G.J., Milone, Giuseppe, Pareja, Macarena Ortiz, Shaheen, Daniel, Willemsen, Arnold, Whitaker, Nicky, Chabannon, Christian
Опубликовано 2013

IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival

по Verhagen, H JMP, de Leeuw, D C, Roemer, M GM, Denkers, F, Pouwels, W, Rutten, A, Celie, P H, Ossenkoppele, G J, Schuurhuis, G J, Smit, L
Опубликовано в: Cell Death Dis (2014)

A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

по Dukers, D F, ten Berge, R L, Oudejans, J J, Pulford, K, Hayes, D, Miseré, J F, Ossenkoppele, G J, Jaspars, L H, Willemze, R, Meijer, C J
Опубликовано 1999

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia

по Hess, C. J., Ameziane, N., Schuurhuis, G. J., Errami, A., Denkers, F., Kaspers, G. J. L., Cloos, J., Joenje, H., Reinhardt, D., Ossenkoppele, G. J., Zwaan, C. M., Waisfisz, Q.
Опубликовано в: Cell Oncol (2008)

CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation

по Stam, A G M, Santegoets, S J A M, Westers, T M, Sombroek, C C, Janssen, J J W M, Tillman, B W, Loosdrecht, A A van de, Pinedo, H M, Curiel, D T, Ossenkoppele, G J, Scheper, R J, de Gruijl, T D
Опубликовано 2003

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

по Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
Опубликовано в: Ann Hematol (2006)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

по Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Опубликовано в: Leukemia (2016)